Inhaled prostacyclin for treatment of pulmonary hypertension after cardiac surgery or heart transplantation: A pharmacodynamic study

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 10, Issue 7, 1996, Pages 864-868

  Haraldsson, A ^a   Kieler Jensen, N ^a   Ricksten, S E ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

aerosolized prostacyclin; cardiac surgery; heart transplantation; pulmonary hypertension

Indexed keywords

ADRENALIN; DOBUTAMINE; INOTROPIC AGENT; ISOPRENALINE; MILRINONE; NORADRENALIN; PHENYLEPHRINE; PROSTACYCLIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HEART RIGHT VENTRICLE FUNCTION; HEART SURGERY; HEART TRANSPLANTATION; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG VASCULAR RESISTANCE; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

EID: 0029754675     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-0770(96)80047-4     Document Type: Article

References (28)

1. Kirklin JK Naftel DC Kirklin JW Pulmonary vascular resistance and the risk of heart transplantation J Heart Transplant 7 1988 331 336
2. Heerdt PM Weiss CI Prostaglandin E1 and intrapulmonary shunt in cardiac surgical patients with pulmonary hypertension Ann Thorac Surg 49 1990 463 465
3. Armitage JM Hardesty RL Griffith BD Prostaglandin E1: An effective treatment of right heart failure after orthotopic heart transplantation J Heart Transplant 6 1987 348 351
4. Fonger JD Borkon AM Baumgartner WA Acute right ventricular failure following heart transplantation: Improvement with prostaglandin E1 and right ventricular assist J Heart Transplant 5 1986 317 321
5. Weiss CI Park JV Bolman RM Prostaglandin E1 for treatment of elevated pulmonary vascular resistance in patients undergoing cardiac transplantation Transplant Proc 21 1989 2555 2556
6. Esmore D Spratt P Branch J Right ventricular assist and prostacyclin infusion for allograft failure in the presence of high pulmonary vascular resistance J Heart Transplant 9 1990 136 141
7. Pascual JMS Fiorelli AI Belotti GM Prostacyclin in the management of pulmonary hypertension after heart transplantation J Heart Transplant 9 1990 644 651
8. Kieler-Jensen N Milocco I Ricksten S-E Pulmonary vasodilation after heart transplantation. A comparison among prostacyclin, sodium nitroprusside and nitroglycerin on right ventricular function and pulmonary selectivity J Heart Lung Transplant 12 1993 179 184
9. Kieler-Jensen N Houltz E Milocco I Central hemodynamics and right ventricular function after coronary artery bypass surgery. A comparison of prostacyclin, sodium nitroprusside and nitroglycerin for treatment of postcardiac surgical hypertension J Cardiothor Vasc Anesth 7 1993 555 559
10. Kieler-Jensen N Lundin S Ricksten S-E Vasodilator therapy after heart transplantation. Effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1 and sodium nitroprusside J Heart Lung Transplant 14 1995 436 443
11. Girard C Lehot JJ Pannetier JC Inhaled nitric oxide after mitral valve replacement in patients with chronic pulmonary artery hypertension Anesthesiology 77 1992 880 883
12. Stenquist O Nathorst-Westfeldt U Lundin S Safety aspects on nitric oxide administration Acta Anaesthesiol Scand 39 suppl 105 1995 60 62
13. Kieler-Jensen N Ricksten S-E Stenqvist O Inhaled nitric oxide in the evaluation of heart-transplant candidates with elevated pulmonary vascular resistance J Heart Lung Transplant 13 1994 366 375
14. Walmrath D Schneider T Pilch J Aerosolized prostacyclin in adult respiratory distress syndrome Lancet 342 1993 961 962
15. Zwissler B Welte M Messmer K Effects of inhaled prostacyclin as compared with inhaled nitric oxide on right ventricular performance in hypoxic pulmonary vasoconstriction J Cardiothor Vasc Anesth 9 1995 283 289
16. Welte M Zwissler B Habazettl H PGI2-aerosol versus nitric oxide for selective pulmonary vasocilation in hypoxic pulmonary vasoconstriction Eur Surg Res 25 1993 329 340
17. Pappert D Busch T Gerlach H Aerosolized prostacyclin versus inhaled nitric oxide in children with severe acute respiratory distress syndrome Anesthesiology 82 1995 1507 1511
18. Zwissler B Rank N Jaenicke U Selective pulmonary vasodilation by inhaled prostacyclin in a newborn with congenital heart disease and cardiopulmonary bypass Anesthesiology 82 1995 1512 1516
19. Ferreira SH Vane JR Prostaglandins: Their disappearance from and release into the circulation Nature 216 1967 868 873
20. Piper PJ Vane JR Wyllie JH Inactivation of prostaglandins by the lungs Nature 225 1970 600 604
21. Waldman HM Alter I Kot PA Effect of lung transit on systemic depressor responses to arachidonic acid and prostacyclin in dogs J Pharmacol Exp Ther 204 1978 289 293
22. Wetzel R Aerosolized prostacyclin: In search of the ideal pulmonary vasodilator Anesthesiology 82 1995 1315 1317
23. Burghuber O Silberbauer K Haber P Pulmonary and antiaggregatory effects of prostacyclin after inhalation and intravenous infusion Respiration 45 1984 450 454
24. Thomas S O'Doherty M Fidler H Pulmonary deposition of a nebulized aerosol during mechanical ventilation Thorax 48 1993 154 159
25. Rossaint R Falke KJ López F Inhaled nitric oxide for the adult respiratory distress syndrome N Engl J Med 328 1993 399 405
26. Miller OI Tang SF Keech A Rebound pulmonary hypertension on withdrawal from inhaled nitric oxide Lancet 346 1995 51 52
27. Petros AJ Down-regulation of endogenous nitric oxide production after prolonged administration Lancet 344 1994 191
28. Kieler-Jensen N Milocco I Kirnö K Effects of prostacyclin on myocardial hemodynamics and metabolism after coronary artery bypass grafting J Cardiothor Vasc Anesth 10 1996 741 747